T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.85% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
First American
FAF
$7.56B
| $12.7M | ﹤0.01% |
224,503
+29,734
| +15% | +$1.62M |
|
|
CNST
1352
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $12.7M | ﹤0.01% |
542,039
+284,777
| +111% | +$8.63M |
|
1353
ePlus
PLUS
$2.31B
| $12.6M | ﹤0.01% |
253,234
-6,132
| -2% | -$291K |
|
1354
Dynatrace
DT
$14.7B
| $12.6M | ﹤0.01% |
261,365
+7,940
| +3% | +$385K |
|
1355
TETRA Technologies
TTI
$1.25B
| $12.5M | ﹤0.01% |
+5,190,194
| New | +$11.2M |
|
1356
Portland General Electric
POR
$5.74B
| $12.5M | ﹤0.01% |
262,283
+229,366
| +697% | +$10M |
|
1357
DXC Technology
DXC
$1.79B
| $12.4M | ﹤0.01% |
396,426
-25,781
| -6% | -$707K |
|
|
LONA
1358
LeonaBio Inc
LONA
$73.9M
| $12.4M | ﹤0.01% |
67,296
-860
| -1% | -$190K |
|
1359
NNN REIT
NNN
$8.79B
| $12.3M | ﹤0.01% |
280,137
+114,698
| +69% | +$4.81M |
|
1360
Aspen Aerogels
ASPN
$504M
| $12.1M | ﹤0.01% |
596,767
+3,458
| +0.6% | +$72.9K |
|
1361
4D Molecular Therapeutics
FDMT
$609M
| $12.1M | ﹤0.01% |
279,746
-63,932
| -19% | -$2.83M |
|
1362
Guidewire Software
GWRE
$15.2B
| $12.1M | ﹤0.01% |
119,014
-26,278
| -18% | -$3.06M |
|
|
PBCT
1363
DELISTED
People's United Financial Inc
PBCT
| $12.1M | ﹤0.01% |
675,144
-34,301
| -5% | -$552K |
|
1364
SiTime
SITM
$20.7B
| $12.1M | ﹤0.01% |
122,405
+117,681
| +2,491% | +$13.8M |
|
1365
Sprott Physical Gold and Silver Trust
CEF
$8.17B
| $12M | ﹤0.01% |
691,178
+243,700
| +54% | +$4.51M |
|
1366
Maravai LifeSciences
MRVI
$861M
| $11.9M | ﹤0.01% |
+334,689
| New | +$11.1M |
|
1367
Genpact
G
$5.78B
| $11.9M | ﹤0.01% |
276,863
+3,153
| +1% | +$131K |
|
1368
Vornado Realty Trust
VNO
$7.33B
| $11.8M | ﹤0.01% |
260,867
-16,527
| -6% | -$685K |
|
|
FLIR
1369
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $11.7M | ﹤0.01% |
207,889
-88,165
| -30% | -$4.79M |
|
1370
Sixth Street Specialty
TSLX
$1.79B
| $11.7M | ﹤0.01% |
555,000
-65,752
| -11% | -$1.41M |
|
1371
Zillow
Z
$8.08B
| $11.5M | ﹤0.01% |
88,344
+5,919
| +7% | +$878K |
|
1372
Globant
GLOB
$1.77B
| $11.4M | ﹤0.01% |
54,777
+3,239
| +6% | +$688K |
|
1373
First Hawaiian
FHB
$3.36B
| $11.4M | ﹤0.01% |
415,005
-355,997
| -46% | -$9.56M |
|
|
CCC
1374
CCC Intelligent Solutions
CCC
$4.19B
| $11.3M | ﹤0.01% |
+1,110,853
| New | +$13.5M |
|
1375
Plug Power
PLUG
$3.21B
| $11.1M | ﹤0.01% |
310,225
+21,006
| +7% | +$1.08M |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.